C vs IOVA · P/E 16, rev $85.22B vs rev $170.7M
Citigroup Inc. (C) versus Iovance Biotherapeutics Inc (IOVA) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
C currently screens at market cap $214.73B and trailing P/E 15.5. IOVA currently screens at market cap $1.89B.
Not investment advice. Open the C and IOVA stock pages for the full models.
Not investment advice.